Skip to main content
University of Michigan Innovation Partnerships
University of Michigan Innovation Partnerships

Portfolio

Aquatonomy

Developing autonomous robotic inspection solutions of critical underwater infrastructure.
(2025)

BlueShift Carbon

Developing technology for direct ocean capture (DOC) of CO2 gas from seawater.
(2025)

Courage Therapeutics

Courage Therapeutics' two drug-development programs aim to address obesity and restrictive eating disorders, such as anorexia nervosa and cachexia, by targeting neural circuits in the brain known as the central melanocortin system.
(2025)

Digital Blue

Advanced process and failure analyses for composite structures.
(2025)

Energy Equity Project

The Energy Equity Project aims to bolster a just transition to cleaner, more resilient energy systems and has developed the first standardized national framework for comprehensively measuring and advancing energy equity.
(2025)

Fibarcode

Developing a system for photonic identification and tracking of textiles.
(2025)

Fragmatics, LLC

Developing and extending the "Gold Standard" in Proteomic search engine optimization and related tools.
(2025)

Genevi Technologies

Developing a medical device to treat stress urinary incontinence.
(2025)

GripFusion

GripFusion is creating and selling an instrumented baseball that can measure and provide analytics on the pressure that is applied to baseball and its flight performance.
(2025)

Heat2Power

Building the next generation of reliable clean energy solutions.
(2025)

Humanica

Software to influence customer behavior by using attachment to peer groups.
(2025)

Joy of Coding

Technology-aided tools for teaching and grading coding.
(2025)

Liferna Biotech

Liferna Biotech is developing a repurposed drug for scleroderma.
(2025)

Media Shield

Media Shield is commercializing software for real-time, AI-driven detection of deepfake audio and video with visual, transparent explainability.
(2025)

NanoOnco

NanoOnco is developing a bioabsorbable magnesium device designed to control cancer and cancer metastasis.
(2025)

Ocutheia

Ocutheia is developing a small molecule as monotherapy for dry and wet age-related macular degeneration.
(2025)

Probetruth

Probetruth is developing solutions to safeguard against deepfakes to preserve the integrity of media.
(2025)

Recens Medical

Rapid precision medical cooling.
(2025)
1 2 3 4 22